Succinylation of Park7 activates a protective metabolic response to acute kidney injury

Katherine Pfister1, Victoria Young1, Brendon Frankel1

  • 1Department of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.

Insights

Lysine succinylation, a posttranslational modification, enhances peroxisomal activity and protects against acute kidney injury (AKI). The Parkinson's-related protein Park7 plays a key role in this protective mechanism, offering new therapeutic targets for kidney disease.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Nephrology

Background:

  • Acute kidney injury (AKI) is a prevalent condition associated with high mortality and progression to chronic kidney disease.
  • Ischemic AKI, often caused by shock or trauma, primarily damages kidney proximal tubule epithelial cells (PTECs).
  • Posttranslational modifications (PTMs), such as lysine succinylation, are increasingly recognized for their role in cellular metabolism and response to injury.

Purpose of the Study:

  • To investigate the role of lysine succinylation in PTEC protection during AKI.
  • To elucidate the function of the Parkinson's-related protein Park7 in AKI pathogenesis and peroxisomal activity.
  • To explore the potential of succinylation as a therapeutic strategy for preventing AKI and its progression.

Main Methods:

  • In vitro and in vivo studies were conducted to assess the effects of lysine succinylation on PTECs.
  • Mass spectrometry-based succinylomic and proteomic analyses were employed to identify changes in protein succinylation and expression.
  • Park7's role in AKI and peroxisome activity was evaluated using cellular and animal models.

Main Results:

  • Lysine hypersuccinylation was found to upregulate peroxisomal activity in PTECs.
  • Park7 was identified as a crucial mediator of protection against AKI and was linked to upregulated peroxisome activity.
  • Data suggest Park7's involvement in the Nrf2 antioxidant response pathway following kidney injury.

Conclusions:

  • Lysine succinylation, particularly involving Park7, represents a novel protective mechanism against ischemic AKI.
  • Targeting Park7 succinylation may offer a therapeutic avenue to ameliorate oxidative damage and prevent kidney disease progression.
  • This study highlights an underappreciated PTM and protein in kidney injury, opening new possibilities for therapeutic development.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
422
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K